THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis

By Coelho Teresa   Maurer Mathew S.   Suhr Ole B.  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 63-76

Informa Healthcare

Access to resources Recommend Favorite

Liver transplantation in transthyretin amyloidosis: Issues and challenges

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 3, 2015-03 ,pp. : 282-292

John Wiley & Sons Inc

Access to resources Recommend Favorite

EWOLUTION: Design of a registry to evaluate real‐world clinical outcomes in patients with AF and high stroke risk‐treated with the WATCHMAN left atrial appendage closure technology

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 88, Iss. 3, 2016-09 ,pp. : 460-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variant transthyretin (TTR) amyloidosis in Argentina. Detection of the trait by electrospray ionization mass spectrometry of lyophilized TTR immunoprecipitate

By Lendoire J. C.   Trigo P.   Aziz H.   Romero M. C.   Inventarza O.   Ando Y.   Tashima K.   Ohlsson P.-I.   Cederquist K.   Holmgren G.   B Suhr O.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 59, Iss. 8, 1999-12 ,pp. : 613-618

Informa Healthcare

Access to resources Recommend Favorite

Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 12, 2015-12 ,pp. : 1098-1104

John Wiley & Sons Inc

Access to resources Recommend Favorite